Newsroom
Ariti S.A. as Sponsor in the Scientific Meeting of the Urodynamics, Neurourology and Female Urology Section of the Hellenic Urological Association, 24 September 2016, Kavala.
Read MoreAriti S.A. as Sponsor in the Scientific Meeting of the Urodynamics, Neurourology and Female Urology Section of the Hellenic Urological Association, 24 September 2016, Kavala.Launch Announcement for new pharmaceutical products 2015-2016
Ariti SA already launches 4 new pharmaceutical products! Oncology Products – Capibine® 150mg & Capibine® 500mg (Active Substance: Capecitabine) for the treatment of several types of cancer – Lutrak® 50mg (Active Substance: Bicalutamide) Antiandrogen for the treatment of prostates cancer – 10GEL® Skin cleansing and relief gel for irradiated skin CNS Products…
Ariti SA supports the cause of “E.M.E.I.S.” 19/09/2014
Ariti SA is supporting the charity concert of the Scientific Oranization E.M.E.I.S which will take place on Friday 19th of September 2014, at Duchess of Plaisance Palace, Athens.
New product release announcement – 04/08/2014
Ariti SA is ready to launch the new pharmaceutical product ARITAXEL® 20mg/0,5ml and ARITAXEL® 80 mg/2ml (Active substance: Docetaxel) for the treatment of several types of cancer.
1st Symposium in Clinical Oncology
Ariti SA participated in the 1st Symposium in Clinical Oncology which took place at Rhodes island in 31 March 2013 ( Rodos Park hotel). The Symposium was organized by the Medical Association of Rhodes.